LOGIN  |  REGISTER
Viking Therapeutics
Recursion

CVS Health Names Heidi Capozzi Executive Vice President, Chief People Officer

August 14, 2024 | Last Trade: US$58.40 0.02 -0.03

WOONSOCKET, R.I., Aug. 14, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Heidi Capozzi will join the company as Executive Vice President, Chief People Officer, effective September 9. She will lead the human resources, labor relations, compensation and benefits, and corporate social responsibility teams who support CVS Health's strategy to build a world of health around every consumer.

"Heidi brings a depth of experience and a breadth of industry insights to CVS Health, in particular a proven track record of hiring, building, and growing strong teams and advancing a winning culture," said CVS Health President and CEO Karen S. Lynch. "From nimble startups to established brands, Heidi has consistently applied her expertise to championing talent and we look forward to her being a part of our leadership team."

Capozzi will be a member of the company's executive leadership team and report to Lynch. Prior to joining CVS Health, she was at McDonald's, serving as Executive Vice President and Global Chief People Officer with responsibility for the company's global human resources operations and leading talent management, learning and development, total rewards, and corporate employee relations. Prior to McDonald's, Capozzi held senior roles in human resources at Boeing, including as Senior Vice President, Human Resources. Her early career included roles across the Human Resources function in large and small enterprises in the defense and automotive industries.

"I am excited to join CVS Health and be part of a team whose strategy is bold and necessary: redefining how health care is delivered in this country," Capozzi said. "I admire CVS Health for its leadership in imagining and delivering a personalized health care experience, and I am proud to join a company that is truly colleague and customer focused with a mission dedicated to improving health for everyone."

Capozzi succeeds Laurie Havanec, who is leaving the company. Havanec played an important leadership role in helping CVS Health successfully navigate many significant moments over the past several years.

About CVS Health

CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health — whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system — and their personal health care — by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.

Media contact
Ethan Slavin
860-273-6095
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Investor contact
Larry McGrath
800-201-0938
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Viking Therapeutics

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB